Evidence map›Paper›PMID 33889204›Full record

ArticleEcancermedicalscience2021

Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer.

Duilio R Rocha-Filho, Renata D'Alpino Peixoto, Rui F Weschenfelder, Juliana F M Rego, Rachel Riechelmann, Anelisa K Coutinho, Gustavo S Fernandes, Alexandre A Jacome, Aline C Andrade, Andre M Murad and 40 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Duilio R Rocha-FilhoHospital Universitário Walter Cantídio, 60430-372 Fortaleza, Brazil.
Renata D'Alpino PeixotoGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Rui F WeschenfelderHospital Moinhos de Vento, 90035-000 Porto Alegre, Brazil.
Juliana F M RegoHospital Universitário Onofre Lopes, 59012-300 Natal, Brazil.
Rachel RiechelmannAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Anelisa K CoutinhoClínica AMO, 41.950-640 Salvador, Brazil.
Gustavo S FernandesHospital Sírio Libanês, 01308-050 São Paulo, Brazil.
Alexandre A JacomeGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Aline C AndradeGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Andre M MuradLaboratório Personal, 30130-090 Fortaleza, Brazil.
Celso A L MelloAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Diego S C G MiguelClínica AMO, 41.950-640 Salvador, Brazil.
Diogo B D GomesHospital Israelita Albert Einstein, 05652-900, São Paulo, Brazil.
Douglas J RacyHospital Beneficência Portuguesa de São Paulo, 01323-001 São Paulo, Brazil.
Eduardo D MoraesGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Eduardo H AkaishiFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Elisangela S CarvalhoHospital São Rafael, 41253-190 Salvador, Brazil.
Evandro S MelloFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Fauze Maluf FilhoFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Felipe J F CoimbraAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Fernanda C CapareliHospital Sírio Libanês, 01308-050 São Paulo, Brazil.
Fernando F ArrudaHospital Sírio Libanês, 01308-050 São Paulo, Brazil.
Fernando M A C VieiraAméricas Oncologia, 22775-001 Rio de Janeiro, Brazil.
Flavio R TakedaFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Guilherme C C CottiHospital Sírio Libanês, 01308-050 São Paulo, Brazil.
Guilherme L S PereiraCentro de Oncologia do Paraná, 81200-100 Curitiba, Brazil.
Gustavo A PauloUniversidade Federal de São Paulo, 04040-003 São Paulo, Brazil.
Héber S C RibeiroAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Laercio G LourencoUniversidade Federal de São Paulo, 04040-003 São Paulo, Brazil.
Marcela CrosaraGrupo Oncologia D'Or, 04535-110 São Paulo, Brazil.
Marcelo G TonetoHospital São Lucas da PUCRS, 90610-000 Porto Alegre, Brazil.
Marcos B OliveiraFaculdade de Ciências Médicas da Santa Casa de São Paulo, 01238-010 São Paulo, Brazil.
Maria de Lourdes OliveiraGrupo Oncologia D'Or, 04535-110 São Paulo, Brazil.
Maria Dirlei BegnamiAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Nora M ForonesUniversidade Federal de São Paulo, 04040-003 São Paulo, Brazil.
Osmar YagiFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Patricia Ashton-ProllaHospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, Brazil.
Patricia B AguillarHospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil.
Paulo C G AmaralClínica AMO, 41.950-640 Salvador, Brazil.
Paulo M HoffGrupo Oncologia D'Or, 04535-110 São Paulo, Brazil.
Raphael L C AraujoUniversidade Federal de São Paulo, 04040-003 São Paulo, Brazil.
Raphael P Di Paula FilhoHospital Alemão Oswaldo Cruz, 01323-020 São Paulo, Brazil.
Rene C GanslGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Roberto A GilGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.
Tulio E F PfifferHospital Sírio Libanês, 01308-050 São Paulo, Brazil.
Tulio SouzaHospital Aliança de Salvador, 41920-900 Salvador, Brazil.
Ulysses RibeiroFaculdade de Medicina da Universidade de São Paulo, 01246903 São Paulo, Brazil.
Victor Hugo F JesusAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Wilson L CostaAC Camargo Cancer Center, 01525-001 Sao Paulo, Brazil.
Gabriel ProllaGrupo Oncoclínicas, 04543-906 São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oesophageal cancer is among the ten most common types of cancer worldwide. More than 80% of the cases and deaths related to the disease occur in developing countries. Local socio-economic, epidemiologic and healthcare particularities led us to create a Brazilian guideline for the management of oesophageal and oesophagogastric junction (OGJ) carcinomas. The Brazilian Group of Gastrointestinal Tumours invited 50 physicians with different backgrounds, including radiology, pathology, endoscopy, nuclear medicine, genetics, oncological surgery, radiotherapy and clinical oncology, to collaborate. This document was prepared based on an extensive review of topics related to heredity, diagnosis, staging, pathology, endoscopy, surgery, radiation, systemic therapy (including checkpoint inhibitors) and follow-up, which was followed by presentation, discussion and voting by the panel members. It provides updated evidence-based recommendations to guide clinical management of oesophageal and OGJ carcinomas in several scenarios and clinical settings.

Indexed as

gastroesophageal cancerguidelinesoesophageal cancer

Identifiers

PMID33889204
PMCPMC8043684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.